Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.

Surakanti SG, Agulnik M.

Semin Oncol. 2008 Jun;35(3):309-19. doi: 10.1053/j.seminoncol.2008.03.009. Review.

PMID:
18544445
[PubMed - indexed for MEDLINE]
2.

Biological therapy of salivary duct carcinoma.

Nashed M, Casasola RJ.

J Laryngol Otol. 2009 Feb;123(2):250-2. doi: 10.1017/S0022215108002314. Epub 2008 Apr 11.

PMID:
18405406
[PubMed - indexed for MEDLINE]
3.

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy.

Prat A, Parera M, Reyes V, Peralta S, Cedrés S, Andreu J, Huguet P, del Campo JM.

Head Neck. 2008 May;30(5):680-3.

PMID:
17972317
[PubMed - indexed for MEDLINE]
4.

Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.

Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, Tsao MS, Siu LL.

J Clin Oncol. 2007 Sep 1;25(25):3978-84.

PMID:
17761983
[PubMed - indexed for MEDLINE]
Free Article
5.

Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.

Schaller G, Fuchs I, Gonsch T, Weber J, Kleine-Tebbe A, Klare P, Hindenburg HJ, Lakner V, Hinke A, Bangemann N.

J Clin Oncol. 2007 Aug 1;25(22):3246-50. Epub 2007 Jun 18.

PMID:
17577021
[PubMed - indexed for MEDLINE]
Free Article
6.

Systemic therapy in the palliative management of advanced salivary gland cancers.

Laurie SA, Licitra L.

J Clin Oncol. 2006 Jun 10;24(17):2673-8. Review.

PMID:
16763282
[PubMed - indexed for MEDLINE]
Free Article
7.

Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.

Haddad R, Colevas AD, Krane JF, Cooper D, Glisson B, Amrein PC, Weeks L, Costello R, Posner M.

Oral Oncol. 2003 Oct;39(7):724-7.

PMID:
12907212
[PubMed - indexed for MEDLINE]
8.

Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients.

Wahlberg P, Anderson H, Biörklund A, Möller T, Perfekt R.

Oral Oncol. 2002 Oct;38(7):706-13.

PMID:
12167424
[PubMed - indexed for MEDLINE]
9.

Carcinoma ex pleomorphic adenoma: a clinicopathologic review.

Olsen KD, Lewis JE.

Head Neck. 2001 Sep;23(9):705-12.

PMID:
11505478
[PubMed - indexed for MEDLINE]
10.

Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.

Lewis JE, Olsen KD, Sebo TJ.

Hum Pathol. 2001 Jun;32(6):596-604.

PMID:
11431714
[PubMed - indexed for MEDLINE]
11.

Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.

Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, Takeyama I.

Laryngoscope. 1992 Aug;102(8):923-7.

PMID:
1353853
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk